Huadong Medicine Co., Ltd (SHE: 000963), a Chinese pharmaceutical company, has announced that it has received marketing approval from the National Medical Products Administration (NMPA) for its Category III medical device, V20. The V20 is an intense pulsed light radiofrequency therapy device designed for various dermatological treatments.
The V20 therapeutic device is comprised of a system console and a handle, offering a comprehensive treatment solution. The system console integrates high-voltage modules, control modules, as well as power and cooling systems. The handle itself includes optional V-ST and VIPL handles, each serving different treatment purposes. The V-ST handle utilizes bipolar radiofrequency for the non-invasive treatment of skin wrinkles. On the other hand, the V-IPL handle features high pulse light and includes five distinct filters for targeted therapies. The HR-630 and HR-570 filters are designed to reduce excess body hair, the SR-580 filter addresses benign pigmented epidermal and skin lesions, the VP-530 filter treats benign skin vascular lesions, and the Acne-415 filter is indicated for the treatment of moderate inflammatory acne. This new product is intended for use in medical institutions, broadening Huadong Medicine’s portfolio in the medical device segment.- Flcube.com
